APGE (Apogee Therapeutics) FCF Margin %: 0.00% (As of Mar. 2026)


APGE Apogee Therapeutics Inc APGE
12 GF Score
Price $132.69
! 3 Warning Signs
View Full Analysis

What is Apogee Therapeutics FCF Margin %?

Apogee Therapeutics APGE -0.14% 12 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates APGE with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 959 Biotechnology companies, Apogee Therapeutics ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Apogee Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-55.57 Mil. Apogee Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Apogee Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Apogee Therapeutics's current FCF Yield % is -2.36%.

The historical rank and industry rank for Apogee Therapeutics's FCF Margin % or its related term are showing as below:


APGE's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Apogee Therapeutics FCF Margin % Related Terms

Apogee Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Apogee Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apogee Therapeutics FCF Margin % Chart

Apogee Therapeutics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
0.00 0.00 0.00 0.00

Apogee Therapeutics Quarterly Data
Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

APGE vs MIRM, PTCT, RYTM: FCF Margin % Comparison

For the Biotechnology subindustry, Apogee Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apogee Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apogee Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Apogee Therapeutics's FCF Margin % falls into.


APGE
12GF Score
Apogee Therapeutics Inc APGE
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apogee Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Apogee Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-232.597/0
= %

Apogee Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-55.57/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Apogee Therapeutics (APGE) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Apogee Therapeutics and its competitors. According to the industry distribution chart, Apogee Therapeutics ranks #999999 out of 959 companies in the Biotechnology industry.
Is Apogee Therapeutics' FCF Margin % too high?
Apogee Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Apogee Therapeutics ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Apogee Therapeutics has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Apogee Therapeutics' FCF Margin % compare to MIRM and PTCT?
According to the Biotechnology industry distribution chart, Apogee Therapeutics ranks #999999 out of 959 companies for FCF Margin %. This places Apogee Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Apogee Therapeutics and its competitors. Apogee Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apogee Therapeutics stock overvalued right now?
Apogee Therapeutics (APGE) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Apogee Therapeutics' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Apogee Therapeutics (APGE), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apogee Therapeutics Business Description

Address 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, USA, 02453
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
12GF Score

Get the complete analysis for APGE

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$132.69
Price